Susquehanna International Group’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,100
Closed -$33.3K 12446
2025
Q3
$33.3K Buy
+16,100
New +$45.1K ﹤0.01% 11960
2024
Q3
Sell
-25,200
Closed -$78.9K 12066
2024
Q2
$78.9K Buy
+25,200
New +$87.5K ﹤0.01% 11182
2023
Q1
Sell
-1,210
Closed -$15.6K 12631
2022
Q4
$15.6K Sell
1,210
-3,220
-73% -$59.4K ﹤0.01% 11839
2022
Q3
$102K Sell
4,430
-340
-7% -$10.3K ﹤0.01% 11687
2022
Q2
$162K Buy
4,770
+210
+5% +$17.1K ﹤0.01% 10925
2022
Q1
$397K Buy
+4,560
New +$273K ﹤0.01% 9563
2021
Q4
Sell
-1,020
Closed -$72K 13155
2021
Q3
$72K Sell
1,020
-290
-22% -$23.4K ﹤0.01% 12212
2021
Q2
$133K Sell
1,310
-570
-30% -$57.7K ﹤0.01% 11924
2021
Q1
$190K Buy
+1,880
New +$193K ﹤0.01% 11463

Other funds holding CELU

Susquehanna International Group's CELU Position: Q1 2026 in Review

Susquehanna International Group sold out of Celularity (CELU) in Q1 2026, closing a stake of 11,727 shares — an estimated $13K sold.

Susquehanna International Group first reported a position in CELU in Q4 2020 and held it in 12 quarters. The position peaked at $2.16M in Q1 2022. 38 funds tracked by Wall St. Rank hold CELU as of Q1 2026.

  • Susquehanna International Group reported no remaining Celularity position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 11,727 Celularity shares in Q1 2026, an estimated $13K.
  • Susquehanna International Group first reported a position in Celularity in Q4 2020 and held it in 12 quarters.
  • Susquehanna International Group's Celularity position peaked at $2.16M in Q1 2022.
  • 38 funds tracked by Wall St. Rank held Celularity as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.